3TT0 image
Deposition Date 2011-09-13
Release Date 2012-06-13
Last Version Date 2024-02-28
Entry Detail
PDB ID:
3TT0
Keywords:
TRANSFERASE/TRANSFERASE INHIBITOR
Title:
Co-structure of Fibroblast Growth Factor Receptor 1 kinase domain with 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (BGJ398)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Trichoplusia ni
Method Details:
Experimental Method:
X-RAY DIFFRACTION
Resolution:
2.80 Å
R-Value Free:
0.26
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
C 1 2 1
3TT0 validation report
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Basic fibroblast growth factor receptor 1
Gene (Uniprot):FGFR1
Mutations:C584S
Chain IDs:A, B
Chain Length:382
Number of Molecules:2
Biological Source:Homo sapiens
UniProt ID:P11362 Pfam ID:PF07714 EC:2.7.10.1
Ligand Molecules
07J
GOL
SO4
Primary Citation
Discovery of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), a potent and selective inhibitor of the fibroblast growth factor receptor family of receptor tyrosine kinase.
J.Med.Chem. 54 7066 7083 (2011)
PMID: 21936542 DOI: 10.1021/jm2006222

Abstact

A novel series of N-aryl-N'-pyrimidin-4-yl ureas has been optimized to afford potent and selective inhibitors of the fibroblast growth factor receptor tyrosine kinases 1, 2, and 3 by rationally designing the substitution pattern of the aryl ring. On the basis of its in vitro profile, compound 1h (NVP-BGJ398) was selected for in vivo evaluation and showed significant antitumor activity in RT112 bladder cancer xenografts models overexpressing wild-type FGFR3. These results support the potential therapeutic use of 1h as a new anticancer agent.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
3TT0